EBM Flashcards

1
Q

According to NHMRC - Level I evidence is?

A

A systematic review of level II studies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

According to NHMRC - Level II evidence is?

A

Depends on the aim. For intervention: Randomised controlled trial For prognosis and aetiology: a prospective cohort study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

According to NHMRC - Level III-1 evidence is?

A

For an intervention, it is a pseudo randomised trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

According to NHMRC - Level III-2 evidence is?

A

A comparative study with concurrent controls: ▪ Non-randomised, experimental trial ▪ Cohort study ▪ Case-control study ▪ Interrupted time series with a control group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

According to NHMRC - Level III-3 evidence is?

A

A comparative study WITHOUT concurrent controls: ▪ Historical control study ▪ Two or more single-arm study ▪ Interrupted time series without a parallel control group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

According to NHMRC - Level IV evidence is?

A

Case series with either post-test or pre-test/post-test outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why have a 2:1 randomisation in a RCT? (4)

A

Easier to recruit - i.e. more likley to get study intervention More numbers in subgroup for later analysis More power when treatment responses are less precise The economical advantage when one arm is more expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name 2 QOL assessment tools?

A

FACT - Functional Assessment of Cancer Therapy (with FACT-En (endometrial) FACT-O (Ovarian)) EORTC - QLQ (Quality of life questionnaires) general and specific cancer tools

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why are QOL important outcome measures? (3)

A
  • They are important to patients
  • Increased cancer survival creates larger groups of survivors with survivorship issues and plans
  • where the treatment offers little benefit the impact of QoL may guide the usage of treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

WHat is HRQOL / HRQL

A

The extent to which one’s usual or expected physical, emotional and social well-being are affected by a medical condition or its treatment

Subjective - appraisal on the impact of illness or its treatment. Pts with the same objective health status can report dissimilar HRQL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does HRQL data inform treatments? (5)

A
  1. In clinical trials - compare treatments and HRQL as a method to determine overall benefit - esp when SE are considerable
  2. Planning for future care - ID requirement for care needs in the future
  3. Capturing changes in status during treatment.
  4. Predicting treatment response - in Lung Ca - change in HRQL predicted response to Rx
  5. Treatment decision-making - prolongation of life, without QOL is not a universally desired goal.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the Warburg effect?

A

Tumours tend to use glycolysis for energy even in aerobic conditions - “aerobic glycolysis”. ? dysfunctional mitochondria may be the cause of a higher rate of glycolysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the SUV

A

SUV is the standardised uptake value. It is a relative measure of FDG uptake in tissues. It is a ratio of the tracer in a region of interest in relation to the amount of FBG and the patients weight. If all the FDG was evenly distributed in the body the SUV would be 1. The SUV of a cervical lesion at Diagnosis was an independent RF for disease recurrence in a retrospective cohort of 287 women with stage IB –IVA Ca. Volume did not correlate with SUV. 3 prognostic groups were identified. SUV Max • = 5.2 = 95% 5yr OS • >5.2 - 13.3 = 70% 5yr OS • >13.3 = 44% 5 yr OS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the criteria for a screening test?

A

Modified Wilson screening criteria IATROGENIC

Important – the condition should be an important one

Acceptable - treatment for the disease

Treatment - and diagnostic facilities should be available

Recognisable - at an early stage of symptoms

Opinions - on who to treat as patients must be agreed

Guaranteed safety e.g. low radiation exposure

Examination - must be acceptable by the patient

Natural history - of the disease must be known

Inexpensive test

Continuous screening i.e. not a one-off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is an odds ratio and how do you calculate one?

A

OR are used to compare the relative odds of the occurrence of the outcome of interest (e.g. disease or disorder), given exposure to the variable of interest (e.g. health characteristic, aspect of medical history).

The OR can also be used to determine whether a particular exposure is a risk factor for a particular outcome, and to compare the magnitude of various risk factors for that outcome.

OR=1 Exposure does not affect odds of the outcome

OR>1 Exposure associated with higher odds of the outcome

OR<1 Exposure associated with lower odds of the outcome

OR = (A/B) / (C/D) = AD / BC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a relative risk and how it is calculated. How does it differ from an OR?

A

The relative risk is the probability of an event in a treatment group (a / a+b) divided by the probability of an event in a non-treatment group (c / c + d)

The OR compares the odds of an event the treatment vs the odds in the control group. The i.e. (a /b) / (c/d)

Calculation of risk needs a people at risk denominator. in Case control or retrospective studies where the number of exposed people is not available the OR is calculate as the RR cannot be calculated. The RR can only be calculated when the people at risk denominator is known.

Multiple logistic regression, a frequently used multivariate technique, calculates adjusted ORs and not RRs.

17
Q

What is propensity score matching?

A

Propensity score matching is a statistical matching technique that attempts to estimate the effect of a treatment (e.g., intervention) by accounting for the factors that predict whether an individual would be eligble for receiving the treatment

A propensity score is the probability of being assigned to a certain treatment, conditional on pre-treatment (or baseline) characteristics.

18
Q

What is a hazard ratio?

A

Hazard ratio (HR) is a measure of an effect of an intervention on an outcome of interest over time.

Most commonly reported in time to event analysis or survival analysis - i.e. how long it takes for an event to occur.

Hazard Ratio (i.e. the ratio of hazards) = Hazard in the intervention group ÷ Hazard in the control group

19
Q

What is Cox model?

A
  • statistical technique for exploring the relationship between the survival of a patient and several explanatory variables.
  • It provides an estimate of the treatment effect on survival after adjustment for other explanatory variables.
  • It allows us to estimate the hazard (or risk) of death, or other event of interest, for individuals, given their prognostic variable
20
Q

What is the cox model

A

statistical technique for exploring the relationship between the survival of a patient and several explanatory variables.

It provides an estimate of the treatment effect on survival after adjustment for other explanatory variables.

It allows us to estimate the hazard (or risk) of death, or other event of interest, for individuals, given their prognostic variables.

21
Q

What is a minimally important difference?

A

The minimally important difference (MID) is the change in score of a patient-reported outcome (either beneficial or harmful) that is important from the patient’s or clinician’s perspective and would warrant a change in the patient’s management

22
Q

What are the WHO HRQOL domains (6)

A

Bag PIPES

Beliefs and values - religion, spirituality, personal beliefs

Physical health - energy & Fatigue, pain & discomfort, sleep and rest

Independence - level of - Mobility, ADL, Dependence of aids and medication, Work capacity

Psychological health - body image and appearance, -ve feelings +ve feelings self-esteem

Environment - financial, physical safety, home environment, participation in and opportunities for leisure

Social relationship - Personal relationship, social support, sexual activity

23
Q

What is conditional relative survival?

A

Conditional relative survival refers to the probability of surviving a number of additional years (e.g. 5 years) after already surviving a specified period of time after cancer diagnosis (e.g. 1 year, 3 years or 5 years)

24
Q

SEER 5yr survival for loc, regional and distant Vaginal Ca?

A

Localised 65%

Regional 54%

Distant 24%

25
Q

SEER 5yr Survival for local, regional and distant vulval Ca?

A

Localised - 86.8%

Regional - 49%

Distant - 21.8 %

26
Q

HGSC 5yr survival by STage I - IV on Cancersurvival stats?

A

I 89%

II 75%

III 45%

IV 28%

27
Q

LSGC - 5yr OS by stage on cancersurvival.com

A

I 94%

II 87%

III 69%

IV 54%

28
Q

SCC Cervix 5yr OS by cancersurvival.com

Adenocarcinoma basically the same

A

I 92%

II 73 %

III 59%

IV 22%

29
Q
A
30
Q

Small Cell carcinoma of the cervix 5yr OS by cancersurvival.com

A

I 87%

II 56%

III 37%

IV 6%

31
Q

Endometrial Ca - survival by grade and stage according to cancersurvival.com

A